Livestreaming Platform Supported by:

custom image custom image custom image

32nd Annual North American Cystic Fibrosis Conference

S21--INF/MIC: Controversies in Airway Infection

Oct 20, 2018 2:30pm ‐ Oct 20, 2018 3:55pm


This session will involve two Pro/Con debates involving issues in airway infection in cystic fibrosis. The first talk will debate whether aggressive antimicrobial management of infants and young children is good or bad. The second debate will be a discussion on whether anaerobes are good or bad actors in the airways of cystic fibrosis individuals.

Learning Objectives:

  • Define the rationale behind aggressive early treatment of young children, and the reasons that treatment may not be beneficial or harmful.
  • Define what is known about the role of anaerobic bacteria in cystic fibrosis in the progression of lung disease and exacerbation.
  • Review treatment options for chronic therapy as well as treatment for pulmonary exacerbations.

Symposium Chair(s):

Symposium Speaker(s):

You must be logged in and own this session in order to post comments.